Ergomed PLC - Guildford, England-based pharmaceutical services company - Regarding its agreed takeover from London-based, healthcare-focused private equity firm Permira Advisers, says all acquisition conditions relating to antitrust and regulatory approvals have been satisfied or waived. The acquisition remains subject to other conditions. The scheme is expected to become effective on November 13.
The deal was agreed in September, with the offer being a payment of 1,350 pence per Ergomed share, valuing the entire company at GBP703.1 million. Ergomed directors at the time said they deemed the offer to be "fair and reasonable", recommending that shareholders vote in favour of the offer at forthcoming court and general meetings.
Current stock price: 1,342.02 pence, up 0.2%
12-month change: up 10%
By Greg Rosenvinge, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
